Antegrade Perfusion With Bacillus Calmette-Guérin in Patients With Non–Muscle-Invasive Urothelial Carcinoma of the Upper Urinary Tract: Who May Benefit?-Reference-Cited by-同舟云学术

Antegrade Perfusion With Bacillus Calmette-Guérin in Patients With Non–Muscle-Invasive Urothelial Carcinoma of the Upper Urinary Tract: Who May Benefit?

Published:2011-11 Issue:5 Volume:60 Page:955-960
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Giannarini Gianluca,Kessler Thomas M.,Birkhäuser Frédéric D.,Thalmann George N.,Studer Urs E.

Publisher

Elsevier BV

Subject

Urology

Reference18 articles.

1. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update;Rouprêt;Eur Urol,2011

2. Adjuvant topical treatment of upper urinary tract urothelial tumours;O’Donoghue;BJU Int,2004

3. Percutaneous bacillus Calmette-Guerin perfusion of the upper urinary tract for carcinoma in situ;Studer;J Urol,1989

4. Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery;Thalmann;J Urol,2002

5. Common Terminology Criteria for Adverse Events v.4.0. National Cancer Institute Web site. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf. Accessed May 20, 2011.

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Organerhaltende Therapien beim Urothelkarzinom des oberen Harntrakts;Die Urologie;2024-09-13

2. Sequential endoluminal gemcitabine and docetaxel vs. Bacillus Calmette–Guérin for the treatment of upper tract carcinoma in situ;Urologic Oncology: Seminars and Original Investigations;2024-07

3. The Utility of Intraluminal Therapies in Upper Tract Urothelial Carcinoma: A Narrative Review;Cancers;2024-05-18

4. Sequential endoluminal gemcitabine and docetaxel for the treatment of clinically non-invasive high-grade upper tract urothelial carcinoma;Urologic Oncology: Seminars and Original Investigations;2024-01

5. Intracavitary Chemotherapy after kidney-Sparing Therapy for Upper Tract Urothelial Carcinoma: A Meta-Analysis;UROL J;2023